• $34.0M
    Market Cap
  • -52.67%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
68,379
+144.25%
27,995
+43.56%
19,500
-46.57%
36,499
+145.17%
Cost of Revenue
128,134
+313.62%
30,979
+21.32%
25,536
-11.27%
28,779
+139.83%
Gross Profit
-59,755
+1,902.51%
-2,984
-50.56%
-6,036
-178.19%
7,720
+167.41%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-352,232
+8.50%
-324,629
-55.69%
-732,698
+113.12%
-343,802
+19.86%
Depreciation and Amortization Expense
374
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
3.1M
+19.37%
2.6M
-6.66%
2.8M
+10.36%
2.5M
+0.83%
Operating Profit
-3.2M
+21.53%
-2.6M
-6.76%
-2.8M
+10.94%
-2.5M
+0.64%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
99,030
+132.36%
-306,064
+201.22%
-101,607
-313.51%
47,588
+283.26%
Income before Taxes
-3.1M
+5.35%
-2.9M
+0.54%
-2.9M
+17.19%
-2.5M
-2.28%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-2.9M
+17.19%
-2.5M
-2.28%
Net Income from Continuing Operations Applicable to Common
-3.1M
+5.35%
-2.9M
+0.54%
-2.9M
+17.19%
-2.5M
-2.28%
Basic EPS and Net Income
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
Diluted EPS and Net Income
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
Basic Weighted Average Shares
452.7M
+10.51%
409.7M
+11.08%
368.8M
+4.95%
351.4M
+7.85%
Diluted Weighted Average Shares
452.7M
+10.51%
409.7M
+11.08%
368.8M
+4.95%
351.4M
+7.85%
Balance Sheet
Cash and Cash Equivalents
1.6M
-29.56%
2.2M
+38.95%
1.6M
-6.67%
1.7M
+6.22%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.6M
-29.56%
2.2M
+38.95%
1.6M
-6.67%
1.7M
+6.22%
Total Current Assets
1.7M
-26.08%
2.2M
+38.71%
1.6M
-7.61%
1.7M
+6.64%
Accumulated Depreciation
374
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
102,811
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
3,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
1.9M
-16.38%
2.2M
+38.71%
1.6M
-7.61%
1.7M
+6.64%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
117,892
+36.75%
86,209
-64.81%
245,004
+199.91%
81,692
-51.06%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
88,851
N/A
N/A
N/A
20,000
0.00%
20,000
+1,509.01%
Total Liabilities
206,743
+139.82%
86,209
-64.81%
245,004
+199.91%
81,692
-51.06%
Retained Earnings
-88.4M
+3.59%
-85.4M
+3.53%
-82.5M
+3.64%
-79.6M
+3.20%
Total Stockholders Equity
N/A
N/A
N/A
N/A
1.4M
-17.82%
1.7M
+13.20%
Total Shares Outstanding
455.5M
+3.32%
440.9M
+13.66%
387.9M
+6.99%
362.5M
+5.53%
Cash Flow
Cash from Operating Activities
-2.1M
+22.19%
-1.7M
+30.24%
-1.3M
+15.44%
-1.1M
+16.21%
Capital Expenditures
103,185
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-103,185
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.5M
-34.60%
2.3M
+95.40%
1.2M
-3.34%
1.2M
-26.78%
Financials Ratio
Gross Margin
-87.39%
+719.85%
-10.66%
-65.56%
-30.95%
-246.34%
21.15%
+9.07%
Operating Margin
-4,628.68%
-50.25%
-9,303.03%
-35.05%
-14,323.83%
+107.65%
-6,898.13%
-58.95%
Return on Assets
N/A
N/A
N/A
N/A
-172.67%
+18.03%
-146.29%
-25.58%
Return on Equity
N/A
N/A
N/A
N/A
-191.31%
+21.15%
-157.92%
-53.16%
Revenue Growth
144.25%
+231.13%
43.56%
+193.54%
-46.57%
-132.08%
145.17%
+28.85%
Current Ratio
14.00
-45.94%
25.91
+294.22%
6.57
-69.19%
21.33
+117.88%
Cash Ratio
13.22
-48.49%
25.66
+294.91%
6.50
-68.88%
20.88
+117.04%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow